|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6812327B1
(en)
|
1996-10-25 |
2004-11-02 |
Human Genome Sciences, Inc. |
Neutrokine-alpha polypeptides
|
|
US7696327B1
(en)
|
1997-10-17 |
2010-04-13 |
Genentech, Inc. |
Antibodies to human Toll homologues
|
|
US20030032090A1
(en)
|
1997-05-07 |
2003-02-13 |
Schering Corporation, A New Jersey Corporation |
Human receptor proteins; related reagents and methods
|
|
WO2001090151A2
(en)
*
|
2000-05-25 |
2001-11-29 |
Schering Corporation |
Human receptor proteins; related reagents and methods
|
|
AU2003203679B2
(en)
*
|
1997-10-17 |
2007-04-05 |
Genentech, Inc. |
Human toll homologues
|
|
AU1070399A
(en)
*
|
1997-10-17 |
1999-05-10 |
Genentech Inc. |
Human toll homologues
|
|
JP2000128900A
(ja)
*
|
1998-10-26 |
2000-05-09 |
Japan Science & Technology Corp |
新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子
|
|
US6303321B1
(en)
|
1999-02-11 |
2001-10-16 |
North Shore-Long Island Jewish Research Institute |
Methods for diagnosing sepsis
|
|
US6740487B1
(en)
*
|
1999-06-10 |
2004-05-25 |
University Of Iowa Research Foundation |
Variant TLR4 nucleic acid and uses thereof
|
|
ATE421584T1
(de)
*
|
1999-11-02 |
2009-02-15 |
Novartis Vaccines & Diagnostic |
Cpg rezeptor (cpg-r) und darauf bezogene methoden
|
|
GB9927332D0
(en)
*
|
1999-11-18 |
2000-01-12 |
Leiv Eiriksson Nyfotek As |
Novel antibody and uses thereof
|
|
GB0001704D0
(en)
*
|
2000-01-25 |
2000-03-15 |
Glaxo Group Ltd |
Protein
|
|
US20030083244A1
(en)
*
|
2000-04-26 |
2003-05-01 |
Vernet Corine A.M. |
Novel proteins and nucleic acids encoding same
|
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
AU2001268427B2
(en)
|
2000-06-16 |
2007-03-29 |
Glaxosmithkline Intellectual Property Limited |
Antibodies that immunospecifically bind to blys
|
|
JP2002034565A
(ja)
*
|
2000-07-19 |
2002-02-05 |
Japan Science & Technology Corp |
細菌ｄｎａを特異的に認識する受容体タンパク質
|
|
EP2267017A3
(en)
*
|
2000-08-18 |
2011-07-06 |
Human Genome Sciences, Inc. |
Binding polypeptides for B lymphocyte stimulator protein (BLyS)
|
|
AU2001288301A1
(en)
|
2000-08-18 |
2002-03-04 |
Human Genome Sciences, Inc. |
Binding polypeptides and methods based thereon
|
|
EP1366077B1
(en)
|
2000-09-15 |
2011-05-25 |
Coley Pharmaceutical GmbH |
PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
|
|
US7304034B2
(en)
|
2001-05-15 |
2007-12-04 |
The Feinstein Institute For Medical Research |
Use of HMGB fragments as anti-inflammatory agents
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
WO2003031573A2
(en)
*
|
2001-10-05 |
2003-04-17 |
Coley Pharmaceutical Gmbh |
Toll-like receptor 3 signaling agonists and antagonists
|
|
DK1719511T3
(da)
*
|
2001-11-16 |
2009-04-14 |
Coley Pharm Group Inc |
N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methansulfonamid, en farmaceutisk sammensætning omfattende samme, og anvendelse deraf
|
|
GB0127618D0
(en)
*
|
2001-11-17 |
2002-01-09 |
Univ Nottingham |
"Composition and method for treatment of wounds"
|
|
JP2004016021A
(ja)
|
2002-06-12 |
2004-01-22 |
Japan Science & Technology Corp |
抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット
|
|
AU2003287316A1
(en)
*
|
2002-12-11 |
2004-06-30 |
3M Innovative Properties Company |
Assays relating to toll-like receptor activity
|
|
WO2004094671A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Coley Pharmaceutical Gmbh |
Methods and products for identification and assessment of tlr ligands
|
|
US7696169B2
(en)
|
2003-06-06 |
2010-04-13 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
AU2004272607B2
(en)
|
2003-09-11 |
2008-11-06 |
Cornerstone Therapeutics Inc. |
Monoclonal antibodies against HMGB1
|
|
TW200514850A
(en)
*
|
2003-10-03 |
2005-05-01 |
Hitachi Chemical Co Ltd |
Method of evaluating risk for viral infection
|
|
US8871782B2
(en)
|
2003-10-03 |
2014-10-28 |
3M Innovative Properties Company |
Alkoxy substituted imidazoquinolines
|
|
TW200516153A
(en)
*
|
2003-10-03 |
2005-05-16 |
Hitachi Chemical Co Ltd |
Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same
|
|
JP2007514648A
(ja)
|
2003-10-24 |
2007-06-07 |
エーザイ株式会社 |
Ｔｏｌｌ−ｌｉｋｅｒｅｃｅｐｔｏｒ２に関連する疾患及び状態を治療するための化合物及び方法
|
|
AR046781A1
(es)
|
2003-11-25 |
2005-12-21 |
3M Innovative Properties Co |
Derivados de imidazoquinolinas. composiciones farmaceuticas.
|
|
JP2008022701A
(ja)
*
|
2004-09-24 |
2008-02-07 |
Japan Science & Technology Agency |
可溶型Ｔｏｌｌ様受容体４タンパク質
|
|
WO2006054129A1
(en)
|
2004-11-19 |
2006-05-26 |
Institut Gustave Roussy |
Improved treatment of cancer by double-stranded rna
|
|
AR051836A1
(es)
|
2004-11-30 |
2007-02-14 |
Centocor Inc |
Antagonistas de receptor 3 simil toll metodos y usos
|
|
AU2006210392A1
(en)
|
2005-02-04 |
2006-08-10 |
Coley Pharmaceutical Group, Inc. |
Aqueous gel formulations containing immune response modifiers
|
|
US7700728B2
(en)
|
2005-03-24 |
2010-04-20 |
Schering Corporation |
Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
|
|
US7498409B2
(en)
|
2005-03-24 |
2009-03-03 |
Schering Corporation |
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
|
|
US9168286B2
(en)
|
2005-10-13 |
2015-10-27 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
|
ES2435775T3
(es)
|
2005-10-27 |
2013-12-23 |
Janssen Biotech, Inc. |
Moduladores de receptor tipo Toll 3, procedimientos y usos
|
|
ES2555544T3
(es)
|
2006-03-07 |
2016-01-04 |
Vaxinnate Corporation |
Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
|
|
WO2007123765A2
(en)
|
2006-03-31 |
2007-11-01 |
Human Genome Sciences Inc. |
Neutrokine-alpha and neutrokine-alpha splice variant
|
|
CN101134046B
(zh)
*
|
2006-09-01 |
2011-10-05 |
中国医学科学院药物研究所 |
Tlr4和tlr9激动剂复方在抑制肿瘤转移中的应用
|
|
EP2155889A4
(en)
*
|
2007-05-25 |
2010-06-16 |
Centocor Ortho Biotech Inc |
TOLL RECEPTOR 3 MODULATORS AND USES THEREOF
|
|
AU2009239655B2
(en)
|
2008-04-25 |
2014-05-22 |
Innate Pharma |
Improved TLR3 agonist compositions
|
|
EP2116602A1
(en)
|
2008-05-07 |
2009-11-11 |
Institut Gustave Roussy |
Combination products for treating cancer
|
|
WO2010031749A1
(en)
|
2008-09-17 |
2010-03-25 |
Innate Pharma |
Compositions and methods for detecting tlr3
|
|
US9512196B2
(en)
|
2008-09-22 |
2016-12-06 |
Cedars-Sinai Medical Center |
Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
|
|
WO2010033294A1
(en)
|
2008-09-22 |
2010-03-25 |
Cedars-Sinai Medical Center |
Short-form human md-2 as a negative regulator of toll-like receptor 4 signaling
|
|
DK2451844T3
(en)
|
2009-07-10 |
2015-07-27 |
Innate Pharma |
Tlr3-retention agents
|
|
WO2011021524A1
(ja)
*
|
2009-08-19 |
2011-02-24 |
国立大学法人名古屋大学 |
乳酸菌の付着性を誘導するペプチド及びその用途
|
|
US9890202B2
(en)
|
2010-07-19 |
2018-02-13 |
Yeda Research And Development Co. Ltd. |
Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
|
|
WO2013054329A1
(en)
*
|
2011-10-10 |
2013-04-18 |
Yeda Research And Development Co. Ltd. |
Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
|
|
WO2012088272A1
(en)
|
2010-12-21 |
2012-06-28 |
Duke University |
Methods and compositions combining immunotherapy with monocyte activation
|
|
US20140065154A1
(en)
|
2011-01-12 |
2014-03-06 |
Innate Pharma |
Tlr3 binding agents
|
|
BR112013030894A2
(pt)
|
2011-06-01 |
2016-08-16 |
Janus Biotherapeutics Inc |
moduladores do sistema imune
|
|
AU2012262021B2
(en)
|
2011-06-01 |
2016-07-28 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
|
CA2850932A1
(en)
|
2011-10-04 |
2013-04-11 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
|
MX361773B
(es)
|
2012-05-31 |
2018-12-17 |
Innate Pharma |
Agentes de ligación a tlr3.
|
|
US10017739B2
(en)
|
2012-09-06 |
2018-07-10 |
Duke University |
Methods of expanding and assessing B cells and using expanded B cells to treat disease
|
|
CN113502299B
(zh)
*
|
2021-07-20 |
2023-03-14 |
中国农业大学 |
一种抗金黄色葡萄球菌遗传修饰山羊生产方法
|